The US Food and Drug Administration (FDA) has warned of the risk of sudden vision loss with Ozempi and other GLP-1 RA drugs.
We are talking about a disease related to damage to the blood supply to the optic nerve. Its exact causes have not yet been proven.
The FDA recommends that patients taking these medications contact their doctor immediately if they experience a sudden deterioration or blurring of vision or changes in color perception.